coronavirus treatment

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

A new study out of the University of Minnesota suggests that anti-malarial drug hydroxychloroquine has no effect on preventing patients from contracting the novel coronavirus.

Results from a phase three trial show that Remdesivir helps recovery in moderately-ill coronavirus patients.

At a press conference on Monday, Admiral Brett Giroir, assistant secretary for health, confirmed that HHS is working with a network of children’s hospitals and intensive care units to better understand the extreme coronavirus symptoms in infected children.

When asked if he takes responsibility for the spike in calls to poison control centers around the country following his on-camera comments about bleach and disinfectant injection as a potential coronavirus treatment, President Donald Trump said, “I can’t imagine why.”

Faced with long odds of survival for COVID-19 patients put on respirators, doctors find alternatives may work better for some.

Ever since the first COVID-19 patients were treated in China, many doctors have assumed ventilators are called for when oxygen levels get so low, they fear a patient could soon die. But now, emergency room doctors in the US are having second thoughts. NBC 6’s Tony Pipitone reports.

Singer Jon Bon Jovi paid a digital visit this week to a kindergarten class, where he helped students strengthen their songwriting skills.

As patients with COVID-19 continue pouring into emergency departments and intensive care units across the nation, an old treatment that has been adapted for a new disease is now being tested in New York, NBC News reports.